STING & TLR Targeting Therapies
Speakers

Associate Professor - Melanoma Medical Oncology - MD Anderson Cancer Center

Chief Scientific Officer - Synlogic

Assistant Professor - Phase, Therapeutics & Melanoma - University of Pittsburgh

Chief Executive Officer - Avidea Technologies
President & CEO - Tallac Therapeutics

CSO, Co-founder, Director & Senior VP - Research & Development - Primmune Therapeutics, Inc.

Director - Mersana Therapeutics
Head of Translational Research & Innovation - Affimed GmbH

Senior Director - Drug Discovery - Vir Biotechnology Inc.

Senior Director & Head of Project Leader Group, Innate Immunity Research Unit - GlaxoSmithKline

Project Leader - F-star Biotechnology Ltd.
Chief Scientific Officer & Executive Vice President - Ryvu Therapeutics

Director - Pharmacology - Codiak Biosciences

Vice President - Research & Cofounder - Actym Therapeutics

M.D. - Innsbruck Medical University

Chief Scientific Officer - STipe Therapeutics

President and CEO - Decoy Biosystems

Senior Scientist - Cancer Immunotherapy Drug Discovery - Mersana Therapeutics

Principal Investigator - Institut Curie

Chief Medical Officer - Seven and Eight Biopharmaceuticals Inc.

Associate Professor - Harvard Medical School

Director - Cancer Research & Scientific - Boehringer Ingelheim

Chief Scientific Officer, Co-founder & Head of Research & Development - Verseau Therapeutics

Chief Computational Scientist - Silicon Therapeutics

Chief Scientific Officer - 4D Pharma PLC

Associate Director, Translational Applications - Nilogen Oncosystems
Senior Vice President - Discovery, Preclinical Models & Services - GenOway
Senior Director - Discovery Research - Myeloid Therapeutics

Associate Director - AstraZeneca

Chief of Research & Development - Silicon Therapeutics
Senior VP Oncology & Translational Medicine, Chief Development Officer ad interim - CureVac

Chief Academic Officer - BILH and BIDMC

Founder, Chief Scientific Officer & Chief Executive Officer - Checkmate Pharmaceuticals

Chief Scientific Officer - Trillium Therapeutics Inc

Chief Medical Officer - Bolt Biotherapeutics

Professor - UMass Medical School

Vice President of Clinical Development - Istari Oncology Inc.

Senior Director - H3 Biomedicine
Booths

4D pharma plc
Developing Science, Delivering Therapies

Nilogen
Make better decisions for your translational immune-oncology program with the most clinically-relevant 3D cancer model – 3D-EXplore

genOway
.

IntoDNA
Where DNA breaks, our insight begins

LinkedIn Drop
Connect with your peers while onsite!